Recently, it has been observed that the chondroitin sulfate proteoglycan neural-glial antigen 2 (NG2) is frequently expressed in ALL with MLL rearrangements and is relatively, though not absolutely, specific. Here, KMT2A is linked to acute lymphoblastic leukemia.